Outsmarting metallo-beta-lactamases by mimicking their natural evolution

Area of Science:

• Biochemistry
• Microbiology
• Evolutionary Biology

Background:

• Metallo-beta-lactamases (MBLs) are enzymes that confer antibiotic resistance by inactivating beta-lactam antibiotics.
• Concerns regarding MBLs stem from their broad substrate specificity, lack of effective inhibitors, and rapid spread.
• The potential for MBLs to evolve into more potent enzymes poses a significant public health risk.

Purpose of the Study:

• To review recent approaches for understanding and predicting the evolution of MBLs.
• To enhance strategies for combating MBL-mediated antibiotic resistance.

Main Methods:

• Literature review of recent research on MBL evolution.
• Analysis of studies involving both naturally occurring and laboratory-generated MBL variants.

Main Results:

• MBLs are evolving, with improved variants emerging in clinical settings and under laboratory conditions.
• Evidence suggests MBLs are relatively novel and in the early stages of their evolutionary trajectory.
• Various research approaches are advancing the ability to mimic and predict MBL evolution.

Conclusions:

• Predicting MBL evolution is crucial for developing effective countermeasures against antibiotic resistance.
• Continued research into MBL evolution will improve our ability to combat resistance.
• Understanding evolutionary dynamics is key to addressing the MBL-mediated public health threat.